Characterization of T cell receptor (TCR) of organ-specific autoimmune disease-inducing T cells and TCR-based immunotherapy with DNA vaccines

Journal of Neuroimmunology

Volumn 110, Issue 1-2, 2000, Pages 1-12

  Matsumoto, Yoh ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

CDR3 spectratyping, DNA vaccine; Multiple sclerosis; Organ specific autoimmune disease; Pathogenic TCR

Indexed keywords

DNA VACCINE; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; CANCER IMMUNOTHERAPY; DISEASE ASSOCIATION; DISEASE SEVERITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE RECEPTOR GENE;

ANIMAL; ENCEPHALOMYELITIS, EXPERIMENTAL AUTOIMMUNE; HUMAN; IMMUNOTHERAPY; MULTIPLE SCLEROSIS; MYOCARDITIS; RECEPTORS, ANTIGEN, T-CELL; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES; VACCINES, DNA;

EID: 0034597083     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00346-5     Document Type: Review

References (58)

1. Acha-Orbea H., Mitchell D.J., Timmermann L., Wraith D.C., Tausch G.S., Waldor M.K., Zamvil S.S., McDevitt H.O., Steinman L. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell. 54:1988;263-273.
2. Afshar G., Muraro P.A., McFarland H.F., Martin R. Lack of over-expression of T cell receptor Vβ5.2 in myelin basic protein-specific T cell lines derived from HLA-DR2 positive multiple sclerosis patients and controls. J. Neuroimmunol. 84:1998;7-13.
3. Barry M.A., Johnston S.A. Biological features of genetic immunization. Vaccine. 15:1997;788-791.
4. Ben-Nun A., Wekerle H., Cohen I.R. Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein. Nature. 292:1981;60-61.
5. Ben-Nun A., Liblau R.S., Lehmann D., Tournier-Lasserve E., Rosenzweig A., Jingwu Z., Raus J.C.M., Bach M.-A. Restricted T-cell receptor Vβ gene usage by myelin basic protein-specific T-cell clones in multiple sclerosis: Predominant genes vary in individuals. Proc. Natl. Acad. Sci. USA. 88:1991;2466-2470.
6. Boyle J.S., Silva A., Brady J.L., Lew A.M. DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity. Proc. Natl. Acad. Sci. USA. 94:1997;14626-14631.
7. Burns J., Rosenzweig A., Zweiman B., Moskovitz A., Lisak R. Recovery of myelin basic protein reactive T cells from spinal cords of Lewis rats with autoimmune encephalomyelitis. J. Immunol. 132:1984;2690-2692.
8. Burns F.R., Li X., Shen N., Offner H., Chou Y.K., Vandenbark A.A., Heber-Katz E. Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar Vα and Vβ chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized are different. J. Exp. Med. 169:1989;27-39.
9. Chan A., Gold R., Giegerich G., Herrmann T., Jung S., Toyka K.V., Hartung H. Usage of V3.3 T-cell receptor by myelin basic protein-specific encephalitogenic T-cell lines in the Lewis rat. J. Neurosci. Res. 58:1999;214-225.
10. Danko I., Fritz J.D., Jiao S., Hogan K., Latendresse J.S., Wolff J.A. Pharmacological enhancement of in vivo foreign gene expression in muscle. Gene Ther. 1:1994;114-121.
11. Desquenne-Clark L., Esch T.R.L., Otvos J., Heber-Katz E. T-cell receptor peptide immunization leads to enhanced and chronic experimental allergic encephalomyelitis. Proc. Natl. Acad. Sci. USA. 88:1991;7219-7223.
12. Feltquate D.M., Heaney S., Webster R.G., Robinson H.L. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J. Immunol. 158:1997;2278-2284.
13. Gold D.P., Offner H., Sun D., Wiley S., Vandenbark A.A., Wilson D.B. Analysis of T cell receptor β chains in Lewis rats with experimental allergic encephalomyelitis: conserved complementarity determining region 3. J. Exp. Med. 174:1991;1467-1476.
14. Gold R., Giegerich G., Hartung H., Toyka K.V. T-cell receptor (TCR) usage in Lewis rat experimental autoimmune encephalomyelitis: TCR β-chain-variable-region Vβ8.2-positive T cells are not essential for induction and course of disease. Proc. Natl. Acad. Sci. USA. 92:1995;5850-5854.
15. Hanawa H., Inomata T., Sekikawa H., Abo T., Kodama M., Izumi T., Shibata A. Analysis of heart-infiltrating T-cell clonotypes in experimental autoimmune myocarditis. Circ. Res. 78:1996;118-125.
16. Howell M.D., Winters S.T., Olee T., Powell H.C., Carlo D.J., Brostoff S.V. Vaccination against experimental allergic encephalomyelitis with T cell receptor peptide. Science. 246:1989;668-670.
17. Inomata T., Hanawa H., Miyanishi T., Yajima E., Nakayama S., Maita T., Kodama M., Izumi T., Shibata A., Abo T. Localization of porcine cardiac myosin epitopes that induce experimental autoimmune myocarditis. Circ. Res. 76:1995;726-733.
18. Kasahara H., Itoh M., Sugiyama T., Kido N., Hayashi H., Saito H., Tsukita S., Kato N. Autoimmune myocarditis induced in mice by cardiac C-protein. J. Clin. Invest. 94:1994;1026-1036.
19. Kawano Y., Sasamoto Y., Kotake S., Thurau S.R., Wiggert B., Gery I. Trials of vaccination against experimental autoimmune uveoretinitis with a T-cell receptor peptide. Curr. Eye Res. 10:1991;789-795.
20. Kim G., Kohyama K., Tanuma N., Arimoto H., Matsumoto Y. Persistent expression of autoimmune encephalomyelitis (EAE)-specific Vβ8.2 TCR spectratype in the central nervous system of rats with chronic relapsing EAE. J. Immunol. 161:1998;6993-6998.
21. Kim G., Tanuma N., Kojima T., Kohyama K., Suzuki Y., Kawazoe Y., Matsumoto Y. CDR3 size spectratyping and sequencing of spectratype-derived T cell receptor of spinal cord T cells in autoimmune encephalomyelitis. J. Immunol. 160:1998;509-513.
22. Kim G., Kohyama K., Tanuma N., Matsumoto Y. Stage-dependent usage of TCR Vα chains with different CDR3 motifs by spinal cord T cells in autoimmune encephalomyelitis. J. Neuroimmunol. 96:1999;66-72.
23. Klinman D.M., Yamshchikov G., Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J. Immunol. 158:1997;3635-3639.
24. Kodama M., Matsumoto Y., Fujiwara M. In vivo lymphocyte-mediated myocardial injuries demonstrated by adoptive transfer of experimental autoimmune myocarditis. Circulation. 85:1992;1918-1926.
25. Kotzin B.L., Karuturi S., Chou Y.K., Lafferty J., Forrester J.M., Better M., Nedwin G.E., Offner H., Vandenbark A.A. Preferential T-cell receptor β-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA. 88:1991;9161-9165.
26. Lannes-Vieira J., Gehrmann J., Kreutzberg G.W., Wekerle H. The inflammatory lesion of T cell line transferred experimental autoimmune encephalomyelitis of the Lewis rats: distinct nature of parenchymal and perivascular infiltrates. Acta Neuropathol. 87:1994;435-442.
27. Lozeron P., Chabas D., Duprey B., Lyon-Caren O., Liblau R. T cell receptor Vβ5 and Vβ17 clonal diversity in cerebrospinal fluid and peripheral blood lymphocytes of multiple sclerosis patients. Multiple Sclerosis. 4:1998;154-161.
28. Madsen L.S., Antersson E.C., Jansson L., Krogsgaard M., Andersen C.B., Engberg J., Strominger J.L., Svejaard A., Hjorth J.P., Holmdahl R., Wucherpennig K.W., Fugger L. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. Nat. Genet. 23:1999;343-347.
29. Maini M.K., Wedderburn L.R., Hall F.C., Wack A., Casorati G., Beverley P.C.L. A comparison of two techniques for the molecular tracking of specific T-cell responses; CD4+ human T-cell clones persist in a stable hierarchy but at a lower frequency than in the CD8+ population. Immunology. 94:1998;529-535.
30. Matsumoto Y., Jee Y., Kim G., Tanuma N. Fine TCR repertoire analysis of spinal cord T cells responding to the major and minor epitopes of myelin basic protein during rat autoimmune encephalomyelitis. J. Neurosci. Res. 59:2000;145-152.
31. Matsumoto Y., Jee Y., Sugisaki M. Successful TCR-based immunotherapy for autoimmune myocarditis with DNA vaccines after rapid identification of pathogenic TCR. J. Immunol. 164:2000;2248-2254.
32. Matsumoto Y., Kim G., Tanuma N. Characterization of T cell receptor associated with the development of P2 peptide-induced autoimmune neuritis. J. Neuroimmunol. 102:2000;67-72.
33. Meini E., Weber F., Drexier K., Morelle C., Ott M., Saruhan-Direskeneli G., Goebels N., Ertl B., Jechart G., Giegerich G., Schoenbeck S., Bannwarth W., Wekerle H., Hohlfeld R. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones. J. Clin. Invest. 92:1993;2633-2643.
34. Musette P., Bequet D., Delarbre C., Gachelin G., Kourilsky P., Dormont D. Expansion of a recurrent Vβ5.3+ T-cell population in newly diagnosed and untreated HLA-DR2 multiple sclerosis patients. Proc. Natl. Acad. Sci. USA. 93:1996;12461-12466.
35. Nanda N.K., Arzoo K.K., Geysen H.M., Sette A., Sercarz E.E. Recognition of multiple peptide cores by a single T cell receptor. J. Exp. Med. 182:1995;531-539.
36. Offner H., Vainiene M., Gold D.P., Celnik B., Wang R., Hashim G.A., Vandenbark A.A. Characterization of the immune response to a secondary encephalitogenic epitope of basic protein in Lewis rats I. T cell receptor peptide regulation of T cell clones expressing cross-reactive Vβ genes. J. Immunol. 148:1992;1706-1711.
37. Oksenberg J.R. The Antigen T Cell Receptor: Selected Protocols and Applications. 1997;Chapman and Hall, New York.
38. Ota K., Matsui M., Milford E.L., Mackin G.A., Weiner H.L., Hafler D.A. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature. 346:1990;183-187.
39. Pannetier C., Even J., Kourilsky P. T-cell repertoire diversity and clonal expansion in normal and clinical sample. Immunol. Today. 16:1995;176-181.
40. Pette M., Fujita K., Wilkinson D., Altmann D.M., Trowsdale J., Giegerch G., Hinkkanen A., Epplen J.T., Kappos L., Wekerle H. Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors. Proc. Natl. Acad. Sci. USA. 87:1990;7968-7972.
41. Pummerer C.L., Luze K., Graessl G., Bachmaier K., Offner F., Burrell S.K., Lenz D.M., Zamborelli T.J., Penninger J.M., Neu N. Identification of cardiac myosin peptides capable of inducing autoimmune myocarditis in BALB/c mice. J. Clin. Invest. 97:1996;2057-2062.
42. Roman M., Martin-Orozco E., Goodman J.S., Nguyen M., Sato Y., Ronaghy A., Kornbluth R.S., Richman D.D., Carson D.A., Raz E. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat. Med. 3:1997;849-854.
43. Sedgwick J.D., MacPhee I.A.M., Puklavec M. Isolation of encephalitogenic CD4+ T cell clones in the rat. Cloning methodology and interferon-γ secretion. J. Immunol. Methods. 121:1989;185-196.
44. Stienekemeier M., Herrmann T., Kruse N., Weishaupt A., Weilbach F.X., Giegerich G., Theofilopoulos A., Jung S., Gold R. Heterogeneity of T-cell receptor usage in experimental autoimmune neuritis in the Lewis rat. Brain. 122:1999;523-535.
45. Stienekemeier M., Weishaupt A., Gold R. Depletion of Vβ4 TCR does not induce resistance of EAN-further evidence for diversity of TCR usage. J. Neuroimmunol. 101:1999;34-38.
46. Sun D., Gold D.P., Smith L., Brostoff S., Coleclough C. Characterization of rat encephalitogenic T cells bearing non-Vβ8 T cell receptor. Eur. J. Immunol. 22:1992;591-594.
47. Sun D., Hu X., Coleclough C. The clonal composition of myelin basic protein-reactive encephalitogenic T cell populations is influenced both by the structure of relevant antigens and the nature of antigen-presenting cells. Eur. J. Immunol. 25:1995;69-74.
48. Tanuma N., Abe S., Shin T., Kojima T., Ishihara Y., Matsumoto Y. Pretreatment with T cell receptor peptide using conventional immunization protocol does not induce effective protection against autoimmune encephalomyelitis. Cell. Immunol. 168:1996;85-90.
49. Tsuchida M., Matsumoto Y., Hirahara H., Hanawa H., Tomiyama K., Abo T. Preferential distribution of Vβ8.2-positive cells in the central nervous system of rats with myelin basic protein-induced autoimmune encephalomyelitis. Eur. J. Immunol. 23:1993;2399-2406.
50. Urban J.L., Kumar V., Kono D.H., Gomez C., Horvath S.J., Clayton J., Ando D.G., Sercarz E.E., Hood L. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell. 54:1988;577-592.
51. Vandenbark A.A., Hashim G., Offner H. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature. 341:1989;541-544.
52. Vandevyver C., Mertens N., van den Elsen P., Medaer R. Raus, J. and Zhang, J., 1995. Clonal expansion of myelin basic protein-reactive T cells in patients with multiple sclerosis: restricted T cell receptor V gene rearrangements and CDR3 sequence. Eur. J. Immunol. 25:(1995):1995;958-968.
53. Wack A., Montagna D., Dellabona P., Casorati G. An improved PCR-heteroduplex method permits high-sensitivity detection of clonal expansion in complex T cell population. J. Immunol. Methods. 196:1996;181-192.
54. Waisman A., Ruiz P., Hirschberg D.L., Gelman A., Oksenberg J.R., Brocke S., Mor F., Cohen I.R., Steinman L. Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nat. Med. 2:1996;899-905.
55. Weilbach F.X., Jung S., Hartung H.-P., Toyka K.V., Giegerich G. T-cell receptor Vβ-element expression in peripheral nerves of Lewis rats suffering from experimental autoimmune neuritis. J. Neuroimmunol. 79:1997;69-75.
56. Wucherpfennig K.W., Ota K., Endo N., Seidman J.G., Posenzweig A., Weiner H.L., Hafler D.A. Shared human T cell receptor Vβ usage to immunodominant regions of myelin basic protein. Science. 248:1990;1016-1019.
57. Zhang X., Heber-Katz E. T cell receptor sequences from encephalitogenic T cells in adult Lewis rats suggest an early ontogenic origin. J. Immunol. 148:1992;746-752.
58. Zhang X., Esch T.R., Clark L., Gregorian S., Rostami A., Otvos L. Jr., Heber-Katz E. Neuritogenic Lewis rat T cells use Tcrb chain that include a new Tcrb-V8 family member. Immunogenetics. 40:1994;266-270.